Hip Replacement Devices Market

• In February 2024, Zimmer Biomet received approval from the U.S. FDA for its ROSA Shoulder System, which includes robot-assisted surgeries for hip replacement. This innovation is part of a broader trend towards robotic surgery in orthopedic procedures, aiming to enhance precision and outcomes

• In August 2022, Exactech Inc. successfully launched the Spartan Stem and Logical Cup system for total hip arthroplasty. This advancement is expected to improve the range of motion and longevity of hip replacement implants, marking a significant development in the hip replacement technology field

In this report, the Hip Replacement Devices Market has been segmented by Product Type, Fixation, End-User, and Geography.

Hip Replacement Devices Market, Segmentation by Product Type

The Hip Replacement Devices Market has been segmented by Product Type into Total Hip Replacement Implants, Partial Hip Replacement Implants, Hip Revision Implants, and Hip Resurfacing Implants.

Total Hip Replacement Implants

Total hip replacement implants dominate the hip replacement market, making up around 45-50% of global procedures. These implants replace both the acetabulum and femoral components, offering enhanced mobility and lasting pain relief for patients with severe hip joint conditions. Innovations like ceramic-on-ceramic and metal-on-polyethylene designs have significantly improved longevity and functionality. The procedure is particularly common among patients over 60, with success rates exceeding 90% after a decade.

Partial Hip Replacement Implants

Also called hemiarthroplasty, partial hip replacement implants are designed for individuals with localized joint damage or hip fractures, representing roughly 25% of hip implant surgeries. By replacing only the femoral head, this approach preserves the acetabulum, resulting in quicker recovery times and less invasive surgery. It is especially suitable for elderly patients or those with multiple health conditions, with a complication rate below 10%.

Hip Revision Implants

Hip revision implants address failures from prior hip replacements, including loosening, wear, or infections, accounting for around 15-20% of the market. These advanced implants often use modular or cementless designs to restore stability and function while compensating for bone loss. Although revision surgeries have longer recovery periods, they provide enhanced joint stability and pain relief for patients requiring corrective procedures.

Hip Resurfacing Implants

For younger, active patients, hip resurfacing implants are a bone-preserving solution, making up about 5-10% of hip replacement procedures. This method caps the femoral head with a metal prosthesis, maintaining most of the natural bone. Patients benefit from improved mobility and a lower risk of dislocation compared to total replacements. Long-term studies show over 85% patient satisfaction when carefully selected for appropriate candidates.

Hip Replacement Devices Market, Segmentation by Fixation

The Hip Replacement Devices Market has been segmented by Fixation into Cemented and Non-Cemented.

Cemented Fixation

Cemented hip implants utilize bone cement to anchor the prosthesis securely, accounting for about 40-45% of global hip replacement surgeries. This method offers immediate stability, making it ideal for elderly patients or those with compromised bone strength. Innovations in PMMA-based bone cement have enhanced the longevity of these implants, with success rates exceeding 85% after 10 years. Cemented fixation is especially beneficial in hip fracture cases, where fast postoperative recovery is critical.

Non-Cemented Fixation

Non-cemented hip implants rely on bone growth into the implant surface for long-term fixation, representing roughly 55-60% of all hip replacement procedures. These implants are favored for younger and more active patients due to their potential for long-lasting durability and minimal cement-related issues. Advanced features like porous coatings and hydroxyapatite layers promote superior bone integration. Long-term studies demonstrate over 90% success rates when patients are carefully selected, positioning non-cemented implants as a top choice in modern orthopedic practice.

Hip Replacement Devices Market, Segmentation by End-User

The Hip Replacement Devices Market has been segmented by End-User into Hospitals, Orthopedic Clinics, and Others.

Hospitals

Hospitals dominate the hip replacement devices market, accounting for around 60-65% of all procedures. With access to advanced surgical equipment and comprehensive postoperative care, hospitals are the go-to choice for both complex and routine hip replacement surgeries. They are also at the forefront of introducing innovative implant technologies, ensuring high success rates and optimal patient recovery across all age groups.

Orthopedic Clinics

Orthopedic clinics handle approximately 25-30% of hip replacement procedures, providing specialized joint care in a focused clinical environment. These clinics are ideal for patients seeking personalized attention, minimally invasive surgeries, and rapid rehabilitation. By integrating modern implant technologies, orthopedic clinics are becoming increasingly popular among younger and more active patients, ensuring effective and targeted hip replacement treatments.

Others

The “Others” segment, including ambulatory surgical centers, rehabilitation facilities, and specialty centers, accounts for roughly 5-10% of procedures. These centers emphasize outpatient care, post-surgery rehabilitation, and secondary procedures. Growing patient preference for cost-effective and convenient treatments, combined with the adoption of advanced implant solutions, is driving gradual growth in this segment.

Hip Replacement Devices Market, Segmentation by Geography

In this report, the Hip Replacement Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Hip Replacement Devices Market Share (%), by Geographical Region

North America

North America dominates the hip replacement devices market, holding around 35-40% of global share. The region benefits from a large aging population, high osteoporosis prevalence, and advanced healthcare systems. Strong adoption of innovative implants and minimally invasive procedures ensures high success rates, with the United States being the key contributor due to its well-equipped hospitals and specialized orthopedic clinics.

Europe

Europe represents approximately 25-30% of the global market for hip replacement devices. Leading countries such as Germany, France, and the UK are adopting robot-assisted surgeries and next-generation implants. Government-backed healthcare initiatives and enhanced rehabilitation programs support growing demand, resulting in improved patient outcomes and broader market penetration.

Asia Pacific

Asia Pacific is an emerging hub for hip replacement devices, contributing around 20-25% of global procedures. The region’s aging population, increasing hip injuries, and expanding healthcare access drive market growth. Countries like Japan, China, and India are increasingly adopting cost-effective implants and minimally invasive surgical techniques, creating substantial opportunities for market expansion.

Middle East and Africa

Middle East and Africa account for roughly 5-7% of global hip replacement procedures. Growth is driven by urbanization, rising healthcare awareness, and the development of specialized orthopedic facilities. While adoption of advanced implants is slower than in developed regions, increasing medical tourism and investments in healthcare infrastructure are gradually expanding market reach.

Latin America

Latin America contributes about 5-8% of the global hip replacement market. The region experiences steady growth through improved healthcare access and increased availability of cemented and non-cemented implants. Key countries like Brazil and Mexico are leading adoption, supported by government initiatives, patient education, and ongoing enhancements in orthopedic treatment facilities.

This report provides an in depth analysis of various factors that impact the dynamics of Global Hip Replacement Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Hip Replacement Devices Market continues to evolve as healthcare providers and manufacturers focus on innovation, collaboration, and patient-centered strategies. Over 65% of companies are investing in advanced implant materials and minimally invasive techniques. The industry’s growth is driven by increasing surgical efficiency, digital monitoring, and sustained R&D efforts improving post-operative outcomes and longevity.

Market Structure and Concentration

The market exhibits a moderately consolidated framework, with about 60% of the share held by major orthopedic firms emphasizing growth through partnerships and innovation alliances. Emerging players contribute through niche product developments and region-specific designs. This combination fosters healthy competition and technological refinement across both primary and revision hip replacement procedures.

Brand and Channel Strategies

Leading manufacturers employ targeted strategies integrating surgeon education, hospital collaborations, and digital sales platforms accounting for nearly 55% of market engagement. Partnerships with healthcare systems enhance product accessibility and clinical performance consistency. Brands strengthen market presence through value-based models, service contracts, and advanced distribution frameworks.

Innovation Drivers and Technological Advancements

Continuous technological advancements define the competitive edge, with over 70% of manufacturers focusing on robotics-assisted surgery, AI-guided planning, and 3D-printed implants. Material innovation in ceramics, titanium, and hybrid coatings improves durability and biocompatibility. These advances are shaping precision-driven treatment paradigms, optimizing recovery, and sustaining long-term growth across orthopedic sectors.

Regional Momentum and Expansion

Regional expansion is gaining momentum, with around 50% of companies enhancing operations across North America, Europe, and Asia-Pacific. Strategic collaboration with local distributors and healthcare facilities boosts adoption in emerging markets. Increased healthcare spending and medical infrastructure upgrades are reinforcing industry growth and accessibility to advanced implant systems.

Future Outlook

The market’s future outlook underscores sustained innovation, digital integration, and patient-focused growth. With nearly 65% of participants investing in smart implant technologies and remote monitoring, collaboration between medtech firms and hospitals is set to expand. Enhanced precision, longevity, and data-driven care will define the next generation of hip replacement devices.

Key players in Hip Replacement Devices Market include:

• DePuy Synthes
• Zimmer Biomet
• Stryker Corporation
• Smith & Nephew
• MicroPort Scientific
• B. Braun Melsungen AG
• Corin
• Waldemar LINK GmbH & Co. KG
• Exactech
• Globus Medical
• OMNIlife Science
• ConMed
• Aesculap Implant Systems
• DJO Global
• Lima Corporate

In this report, the profile of each market player provides following information:

• Market Share Analysis
• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis